• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症和营养标志物对结直肠癌腹膜转移患者的预后影响

Prognostic impact of inflammatory and nutritional markers in colorectal cancer patients with peritoneal metastasis.

作者信息

Cai Zhao, Dai Wei-De, Cai Xiong-Wei

机构信息

Department of Ultrasound, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100005, China.

Department of Gynecology, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing 410013, China.

出版信息

World J Gastrointest Oncol. 2025 Jun 15;17(6):100010. doi: 10.4251/wjgo.v17.i6.100010.

DOI:10.4251/wjgo.v17.i6.100010
PMID:40547170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12179944/
Abstract

In this article, we critically appraise the study by Wu , which investigated the prognostic value of preoperative inflammatory and nutritional markers in colorectal cancer patients with peritoneal metastasis. This retrospective cohort study included 133 patients. The findings indicate that patients with high neutrophil-to-lymphocyte ratios (NLRs) or lower hemoglobin (Hb) levels have significantly shorter overall survival (OS) than those with lower NLRs or normal Hb levels, respectively. Furthermore, age, carbohydrate antigen 199 levels, the NLR, Hb, and the peritoneal cancer index were identified as independent prognostic factors for OS. A nomogram was subsequently developed, demonstrating its ability to accurately predict the OS of colorectal cancer patients with peritoneal metastasis. This study introduces a potentially valuable prognostic tool for these patients. However, further validation in multicenter cohorts is needed to confirm its clinical applicability, to assess its limitations, and to elucidate the underlying mechanism of these identified biomarkers.

摘要

在本文中,我们对吴的一项研究进行了批判性评价,该研究调查了术前炎症和营养标志物对结直肠癌腹膜转移患者的预后价值。这项回顾性队列研究纳入了133例患者。研究结果表明,中性粒细胞与淋巴细胞比值(NLR)高或血红蛋白(Hb)水平低的患者,其总生存期(OS)分别显著短于NLR低或Hb水平正常的患者。此外,年龄、糖类抗原199水平、NLR、Hb和腹膜癌指数被确定为OS的独立预后因素。随后制定了一个列线图,证明其能够准确预测结直肠癌腹膜转移患者的OS。这项研究为这些患者引入了一种潜在有价值的预后工具。然而,需要在多中心队列中进行进一步验证,以确认其临床适用性,评估其局限性,并阐明这些已确定生物标志物的潜在机制。

相似文献

1
Prognostic impact of inflammatory and nutritional markers in colorectal cancer patients with peritoneal metastasis.炎症和营养标志物对结直肠癌腹膜转移患者的预后影响
World J Gastrointest Oncol. 2025 Jun 15;17(6):100010. doi: 10.4251/wjgo.v17.i6.100010.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
5
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
8
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Integrating inflammation, nutrition, and artificial intelligence: A new era in colorectal cancer prognostic scoring.整合炎症、营养与人工智能:结直肠癌预后评分的新时代。
World J Gastroenterol. 2025 Aug 14;31(30):108431. doi: 10.3748/wjg.v31.i30.108431.

本文引用的文献

1
Impact of preoperative inflammatory and nutritional markers on the prognosis of patients with peritoneal metastasis of colorectal cancer.术前炎症和营养指标对结直肠癌腹膜转移患者预后的影响。
World J Gastrointest Oncol. 2024 Sep 15;16(9):3865-3874. doi: 10.4251/wjgo.v16.i9.3865.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.结直肠癌中的肿瘤相关巨噬细胞(TAMs):从机制到治疗和预后。
Int J Mol Sci. 2021 Aug 6;22(16):8470. doi: 10.3390/ijms22168470.
4
Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients.炎症相关生物标志物预测结直肠癌患者预后。
Int J Mol Sci. 2021 Jul 27;22(15):8002. doi: 10.3390/ijms22158002.
5
The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.联合全身炎症反应指标对结肠癌患者预后的预测价值:1700 例患者分析。
Br J Cancer. 2021 May;124(11):1828-1835. doi: 10.1038/s41416-021-01308-x. Epub 2021 Mar 24.
6
Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer.术前炎症和营养标志物对结直肠癌的预后价值
Front Oncol. 2020 Nov 3;10:585083. doi: 10.3389/fonc.2020.585083. eCollection 2020.
7
Colorectal cancer.结直肠癌。
Lancet. 2019 Oct 19;394(10207):1467-1480. doi: 10.1016/S0140-6736(19)32319-0.
8
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.结直肠癌转移的靶向治疗:分子靶向治疗的当前方法综述及肿瘤标志物在转移性结直肠癌治疗中的应用。
Cancer. 2019 Dec 1;125(23):4139-4147. doi: 10.1002/cncr.32163. Epub 2019 Aug 21.
9
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.白细胞增多和中性粒细胞增多作为 CAO/ARO/AIO-04 随机 3 期直肠癌试验中独立的预后免疫生物标志物预测临床结局。
Int J Cancer. 2019 Oct 15;145(8):2282-2291. doi: 10.1002/ijc.32274. Epub 2019 Apr 2.
10
Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.术前化疗期间肌肉质量丢失可预测结直肠肝转移患者的生存不良。
Surgery. 2019 Feb;165(2):329-336. doi: 10.1016/j.surg.2018.07.031. Epub 2018 Sep 6.